- Home
- Labeler Index
- Meda Pharmaceuticals Inc.
- 0037-0022
- NDC Crossover: 0037-0022 Sfrowasa Sulfite-free Formulation
NDC Crossover 0037-0022 Sfrowasa Sulfite-free Formulation
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Mesalamine
Explore similar products and medications to NDC 0037-0022 Sfrowasa Sulfite-free Formulation a human prescription drug with other products crossover matching the same product name (Sfrowasa Sulfite-free Formulation) or generic name (Mesalamine), and the same administration route (rectal) or dosage form (suspension). This comprehensive list of related drugs for easy comparison is ideal for healthcare professionals & patients seeking alternatives.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0037-0066 | Rowasa | Mesalamine | Suspension | Rectal | Meda Pharmaceuticals Inc. | Human Prescription Drug |
21922-045 | Mesalamine | Mesalamine | Suspension | Rectal | Encube Ethicals Private Limited | Human Prescription Drug |
45802-098 | Mesalamine | Mesalamine | Enema | Rectal | Padagis Israel Pharmaceuticals Ltd | Human Prescription Drug |
62559-420 | Mesalamine | Mesalamine | Enema | Rectal | Ani Pharmaceuticals, Inc. | Human Prescription Drug |